Related references
Note: Only part of the references are listed.Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study
Susan Friend et al.
BMC NEUROLOGY (2016)
Interferon-beta exposure during first trimester is safe in women with multiple sclerosisA prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry
Sandra Thiel et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
The Swiss Multiple Sclerosis Cohort-Study (SMSC): A Prospective Swiss Wide Investigation of Key Phases in Disease Evolution and New Treatment Options
Giulio Disanto et al.
PLOS ONE (2016)
Interferon-beta exposure during first trimester is safe in women with multiple sclerosisA prospective cohort study from the German Multiple Sclerosis and Pregnancy Registry
Sandra Thiel et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
GLATIRAMER ACETATE AND PREGNANCY IN WOMEN WITH MULTIPLE SCLEROSIS – RESULTS FROM THE GERMAN MULTIPLE SCLEROSIS AND PREGNANCY REGISTRY
Sandra Herbstritt et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2015)
An overview of pregnancy-related issues in patients with multiple sclerosis
C. Pozzilli et al.
EUROPEAN JOURNAL OF NEUROLOGY (2015)
Multiple sclerosis and pregnancy in the 'treatment era'
Sandra Vukusic et al.
NATURE REVIEWS NEUROLOGY (2015)
Pregnancy outcomes in patients exposed to interferon beta-1b
Rebecca S. Romero et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Multiple Sclerosis: Current Knowledge and Future Outlook
Christian P. Kamm et al.
EUROPEAN NEUROLOGY (2014)
Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis
Goeril Karlsson et al.
NEUROLOGY (2014)
Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events
P. K. Coyle et al.
BMJ OPEN (2014)
Natalizumab Use During the Third trimester of Pregnancy
Aiden Haghikia et al.
JAMA NEUROLOGY (2014)
Pregnancy Outcomes Following Maternal and Paternal Exposure to Teriflunomide During Treatment for Relapsing-Remitting Multiple Sclerosis
Bernd C. Kieseier et al.
NEUROLOGY AND THERAPY (2014)
Sex and gender issues in multiple sclerosis
Hanne F. Harbo et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2013)
Multiple sclerosis and pregnancy: experience from a nationwide database in Germany
Kerstin Hellwig et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2012)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
Unintended pregnancy in the United States: incidence and disparities, 2006
Lawrence B. Finer et al.
CONTRACEPTION (2011)
Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy
Magnhild Sandberg-Wollheim et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study
C. Weber-Schoendorfer et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Share Paper
